Destiny Hinton

Myelodysplastic syndromes can lead to leukemia in children. Considered an adult disease, researchers have found molecular differences that may offer new treatments for children with pediatric MDS.

Learn how breastfeeding helps childhood cancer survivors reduce late effects, the health problems that occur months or years after treatment.

The most important part of research is that you must not fool yourself — and you’re the easiest person to fool.

Read how the oncogene MYCN hijacks an oxygen-carrying component of hemoglobin to feed and grow aggressive AML in children.

Gene therapy for X-linked SCID resulted in the development of T cell, B cell and natural killer cells without side effects. Read more about the research.

Jun J. Yang, PhD, shares research presented at ASH that highlights the role the GATA3 oncogene plays in a high-risk subset of acute lymphoblastic leukemia.

The annual American Society of Hematology (ASH) meeting offers St. Jude clinicians and researchers the opportunity to learn, network and recruit. Read more.

Learn about new equations to estimate kidney function in young cancer patients more quickly and accurately.

Jun J. Yang, PhD, offers highlights of the first ALL session at the American Society of Hematology (ASH) meeting, including his work on TP53. Read more.

Find out how a researcher applied statistical analysis to chart variance and better understand how childhood leukemia develops.